{"id":27613,"date":"2026-08-04T08:36:44","date_gmt":"2026-08-04T08:36:44","guid":{"rendered":"https:\/\/quickbirdmedical.com\/?post_type=news&p=27613"},"modified":"2026-08-20T13:10:58","modified_gmt":"2026-08-20T13:10:58","slug":"abem-diga-compensation-performance-measurement","status":"publish","type":"news","link":"https:\/\/quickbirdmedical.com\/en\/news\/abem-diga-compensation-performance-measurement\/","title":{"rendered":"DiGA Reimbursement: Performance Measurement Begins, Volume Discounts Approved"},"content":{"rendered":"

As of July 1, 2026, Phase I of the in-use performance measurement (AbEM)<\/strong> applies to all permanently listed digital health applications (DiGA).<\/p>\n

According to Section 23c(1) of the DiGAV, DiGA manufacturers must submit the following data for the third and fourth quarters of 2026:<\/p>\n

\u201cThe results of the performance measurement conducted throughout the application period regarding the duration and frequency of use include an analysis of the data collected from the start of use through the end of the application period.\u201d<\/em><\/p>\n

    \n
  1. Regarding the scope of use,<\/em><\/li>\n
  2. on frequency of use and<\/em><\/li>\n
  3. “to discontinue use.”<\/em><\/li>\n<\/ol>\n

    For more detailed information on the required data sets, please refer to Appendix 4 of the DiGAV<\/a>.<\/p>\n

    The first data submission to the BfArM is<\/strong> scheduled<\/strong> for April 15, 2027<\/strong>, followed by semi-annual submissions. In addition, starting in 2026, at least 20% of DiGA reimbursement must be performance-based.<\/p>\n

    Phase II<\/strong> of the real-world outcomes measurement (patient-reported health status, patient satisfaction) will begin on July 1, 2027<\/strong>.<\/p>\n

    Read more about this on the BfArM website: Digital Health Applications (DiGA)<\/a><\/p>\n

    Under the Statutory Health Insurance Contribution Rate Stabilization Act (GKV-BStabG) <\/strong>, a volume-based discount<\/strong> on DiGA reimbursement amounts will <\/strong>also take effect <\/strong>on January 1, 2027. The reduction is based on the annual volume of DiGA submissions and ranges from a minimum of 2% for more than 3,000 submissions to a minimum of 30% for more than 100,000 submissions per year.<\/strong><\/p>\n

    The background to this is the Cost Structure of Digital Goods<\/strong>: High fixed costs for development are offset by low variable costs for reproduction and distribution; the low marginal costs associated with high sales volumes are to be accounted for through standardized discounts.<\/p>\n

    In addition, mandatory thresholds<\/strong> and a maximum amount<\/strong> are provided for DiGAs<\/strong> that cannot be assigned to a group of comparable applications. This catch-all amount is weighted based on the level of service utilization.<\/p>\n

    The text of the resolution is available here: Bundestag Resolution (PDF)<\/a><\/p>\n","protected":false},"featured_media":0,"template":"","categories":[],"tags":[],"display":[54],"class_list":["post-27613","news","type-news","status-publish","hentry","display-display-on-news-page"],"acf":[],"yoast_head":"\nDiGA Reimbursement: Performance Measurement Begins, Including Volume Discounts<\/title>\n<meta name=\"description\" content=\"Since July 1, 2026, Phase I of the AbEM performance measurement applies to all permanently listed DiGA, with data due for Q3 and Q4 of 2026.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/quickbirdmedical.com\/en\/news\/abem-diga-compensation-performance-measurement\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DiGA Reimbursement: Performance Measurement Begins, Including Volume Discounts\" \/>\n<meta property=\"og:description\" content=\"Since July 1, 2026, Phase I of the AbEM performance measurement applies to all permanently listed DiGA, with data due for Q3 and Q4 of 2026.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/quickbirdmedical.com\/en\/news\/abem-diga-compensation-performance-measurement\/\" \/>\n<meta property=\"og:site_name\" content=\"QuickBird Medical\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-20T13:10:58+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/quickbirdmedical.com\\\/en\\\/news\\\/abem-diga-compensation-performance-measurement\\\/\",\"url\":\"https:\\\/\\\/quickbirdmedical.com\\\/en\\\/news\\\/abem-diga-compensation-performance-measurement\\\/\",\"name\":\"DiGA Reimbursement: Performance Measurement Begins, Including Volume Discounts\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/quickbirdmedical.com\\\/en\\\/#website\"},\"datePublished\":\"2026-08-04T08:36:44+00:00\",\"dateModified\":\"2026-08-20T13:10:58+00:00\",\"description\":\"Since July 1, 2026, Phase I of the AbEM performance measurement applies to all permanently listed DiGA, with data due for Q3 and Q4 of 2026.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/quickbirdmedical.com\\\/en\\\/news\\\/abem-diga-compensation-performance-measurement\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/quickbirdmedical.com\\\/en\\\/news\\\/abem-diga-compensation-performance-measurement\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/quickbirdmedical.com\\\/en\\\/news\\\/abem-diga-compensation-performance-measurement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/quickbirdmedical.com\\\/en\\\/home-neu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DiGA Reimbursement: Performance Measurement Begins, Volume Discounts Approved\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/quickbirdmedical.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/quickbirdmedical.com\\\/en\\\/\",\"name\":\"QuickBird Medical\",\"description\":\"Entwicklung von medizinischer Software und DiGA\",\"publisher\":{\"@id\":\"https:\\\/\\\/quickbirdmedical.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/quickbirdmedical.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/quickbirdmedical.com\\\/en\\\/#organization\",\"name\":\"QuickBird Medical\",\"url\":\"https:\\\/\\\/quickbirdmedical.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/quickbirdmedical.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/quickbirdmedical.com\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/QBM_Logo_web-01-1.webp\",\"contentUrl\":\"https:\\\/\\\/quickbirdmedical.com\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/QBM_Logo_web-01-1.webp\",\"width\":875,\"height\":255,\"caption\":\"QuickBird Medical\"},\"image\":{\"@id\":\"https:\\\/\\\/quickbirdmedical.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/de.linkedin.com\\\/showcase\\\/quickbird-medical\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DiGA Reimbursement: Performance Measurement Begins, Including Volume Discounts","description":"Since July 1, 2026, Phase I of the AbEM performance measurement applies to all permanently listed DiGA, with data due for Q3 and Q4 of 2026.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/quickbirdmedical.com\/en\/news\/abem-diga-compensation-performance-measurement\/","og_locale":"en_US","og_type":"article","og_title":"DiGA Reimbursement: Performance Measurement Begins, Including Volume Discounts","og_description":"Since July 1, 2026, Phase I of the AbEM performance measurement applies to all permanently listed DiGA, with data due for Q3 and Q4 of 2026.","og_url":"https:\/\/quickbirdmedical.com\/en\/news\/abem-diga-compensation-performance-measurement\/","og_site_name":"QuickBird Medical","article_modified_time":"2026-08-20T13:10:58+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/quickbirdmedical.com\/en\/news\/abem-diga-compensation-performance-measurement\/","url":"https:\/\/quickbirdmedical.com\/en\/news\/abem-diga-compensation-performance-measurement\/","name":"DiGA Reimbursement: Performance Measurement Begins, Including Volume Discounts","isPartOf":{"@id":"https:\/\/quickbirdmedical.com\/en\/#website"},"datePublished":"2026-08-04T08:36:44+00:00","dateModified":"2026-08-20T13:10:58+00:00","description":"Since July 1, 2026, Phase I of the AbEM performance measurement applies to all permanently listed DiGA, with data due for Q3 and Q4 of 2026.","breadcrumb":{"@id":"https:\/\/quickbirdmedical.com\/en\/news\/abem-diga-compensation-performance-measurement\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/quickbirdmedical.com\/en\/news\/abem-diga-compensation-performance-measurement\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/quickbirdmedical.com\/en\/news\/abem-diga-compensation-performance-measurement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/quickbirdmedical.com\/en\/home-neu\/"},{"@type":"ListItem","position":2,"name":"DiGA Reimbursement: Performance Measurement Begins, Volume Discounts Approved"}]},{"@type":"WebSite","@id":"https:\/\/quickbirdmedical.com\/en\/#website","url":"https:\/\/quickbirdmedical.com\/en\/","name":"QuickBird Medical","description":"Entwicklung von medizinischer Software und DiGA","publisher":{"@id":"https:\/\/quickbirdmedical.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/quickbirdmedical.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/quickbirdmedical.com\/en\/#organization","name":"QuickBird Medical","url":"https:\/\/quickbirdmedical.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/quickbirdmedical.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/quickbirdmedical.com\/wp-content\/uploads\/2022\/06\/QBM_Logo_web-01-1.webp","contentUrl":"https:\/\/quickbirdmedical.com\/wp-content\/uploads\/2022\/06\/QBM_Logo_web-01-1.webp","width":875,"height":255,"caption":"QuickBird Medical"},"image":{"@id":"https:\/\/quickbirdmedical.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/de.linkedin.com\/showcase\/quickbird-medical\/"]}]}},"_links":{"self":[{"href":"https:\/\/quickbirdmedical.com\/en\/wp-json\/wp\/v2\/news\/27613","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quickbirdmedical.com\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/quickbirdmedical.com\/en\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/quickbirdmedical.com\/en\/wp-json\/wp\/v2\/media?parent=27613"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/quickbirdmedical.com\/en\/wp-json\/wp\/v2\/categories?post=27613"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/quickbirdmedical.com\/en\/wp-json\/wp\/v2\/tags?post=27613"},{"taxonomy":"display","embeddable":true,"href":"https:\/\/quickbirdmedical.com\/en\/wp-json\/wp\/v2\/display?post=27613"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}